x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Pilot Study to Evaluate the Efficacy and Safety of Plasma Exchange with Albutein 5% in Patients with Amyotrophic Lateral Sclerosis
Principal Investigator (?)
Study Number
F16029
Summary
This is a pilot, phase 2, prospective, open-label, single-arm study to evaluate disease progression, forced vital capacity, and the safety and tolerability of plasma exchange (PE) using Albutein® 5% in subjects with amyotrophic lateral sclerosis (ALS). 
Phase (?)
Phase III
Sponsor (?)
Contact

Catherine Andrews

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0